476 First-in-human phase 1/2 study of the first-in-class
476 First-in-human phase 1/2 study of the first-in-class,Biological Significance of Focal Adhesion Kinase in Ovarian,交流電源雑音防止用(海外規格認定品)LHXK721 神栄キャパシタ,Repurposing the KCa3.1 Blocker Senicapoc for Ischemic Stroke,Figure 4 from Decrease of ZEB1 expression inhibits the